introduct
neg
stain
base
aqueou
suspens
biolog
particl
deposit
grid
stain
heavi
metal
salt
uranyl
acet
phosphotungst
acid
improv
observ
viral
particl
pave
way
widespread
use
tem
basic
virolog
rapid
diagnosi
viral
figur
neg
stain
clearli
distinguish
viral
particl
background
provid
precis
morpholog
inform
concern
symmetri
presenc
absenc
envelop
exampl
facilit
specif
identif
virus
least
classif
morpholog
similar
group
use
tem
viral
studi
peak
techniqu
contribut
discoveri
mani
clinic
import
virus
reovirus
isol
observ
propag
cell
cultur
vitro
differ
viru
size
fine
structur
use
criteria
precis
howev
tem
initi
fail
detect
agent
diseas
hepat
gastroenter
causal
virus
could
propag
cell
cultur
vitro
nevertheless
applic
tem
dirti
clinic
sampl
plasma
urin
fece
constitut
major
breakthrough
studi
etiolog
agent
hepat
detect
plasma
stool
sampl
respect
bk
viru
polyomaviru
identifi
first
time
urin
patient
undergo
renal
rotavirus
also
identifi
tem
main
caus
epidem
gastroenter
human
howev
mani
virus
also
found
caus
gastroenter
first
virus
norwalk
viru
identifi
outbreak
gastroenter
norwalk
ohio
virus
similar
morpholog
subsequ
discov
elsewher
call
virus
reflect
similar
appear
offici
renam
norovirus
virus
famili
also
identifi
stool
sampl
children
gastroenter
tem
thu
wide
use
neg
stain
sampl
routin
diagnosi
rapid
method
distinguish
divers
virus
potenti
implic
human
gastroenter
provid
diagnosi
within
minut
arriv
sampl
laboratori
although
due
need
emb
sampl
resin
cut
ultrathin
section
ultramicrotom
tem
also
prove
use
medic
virolog
search
virus
tissu
panel
e
f
figur
illustr
parapoxviru
orf
viru
visual
skin
biopsi
specimen
patient
sever
finger
polyomaviru
bk
viru
cell
collect
urin
renal
transplant
patient
respect
major
chang
diagnosi
viral
infect
occur
advent
sensit
molecular
techniqu
immunosorb
assay
elisa
polymeras
chain
reaction
pcr
particular
molecular
techniqu
advantag
greater
sensit
capac
process
larg
number
sampl
easili
replac
tem
mani
area
virolog
diagnosi
case
particular
diagnosi
viral
gastroenter
molecular
techniqu
capabl
identifi
viru
famili
involv
human
gastroenter
similar
shift
practic
occur
veterinari
medicin
elisa
pcr
progress
replac
tem
routin
diagnosi
viral
human
medicin
use
tem
differenti
smallpox
viru
virus
present
fluid
cutan
vesicl
longer
requir
sinc
success
erad
variola
viru
thank
worldwid
vaccin
argu
tem
remain
potenti
use
applic
context
howev
risk
smallpox
reappear
extrem
small
even
unlik
event
happen
molecular
techniqu
would
undoubtedli
outperform
tem
diagnosi
consequ
number
laboratori
make
use
tem
diagnost
purpos
decreas
consider
tem
remain
use
resolv
certain
diagnost
problem
medic
virolog
clearli
illustr
sever
remark
occas
last
year
case
tem
use
character
viru
directli
patient
sampl
isol
viru
clinic
sampl
propag
cell
cultur
vitro
outbreak
fatal
respiratori
diseas
hors
ill
human
australia
tem
prove
essenti
identif
previous
unknown
viru
hendra
viru
recogn
member
paramyxovirida
famili
basi
relat
viru
nipah
viru
also
first
identifi
tem
cerebrospin
fluid
outbreak
enceph
malaysia
singapor
men
expos
etiolog
sever
acut
respiratori
syndrom
sar
pandem
hong
kong
southern
china
also
initi
determin
tem
causal
viru
isol
sever
laboratori
around
world
inocul
cell
cultur
respiratori
specimen
lead
identif
coronaviru
ultrathin
tem
section
outbreak
unidentifi
rash
human
associ
ill
prairi
dog
occur
unit
state
tem
reveal
presenc
poxviru
cell
cultur
isol
viru
later
identifi
monkeypox
etiolog
agent
respons
acut
sever
fever
thrombocytopenia
syndrom
sft
six
provinc
china
diagnos
use
tem
investig
cell
cultur
presenc
blood
sampl
patient
diseas
tem
reveal
presenc
virion
characterist
morpholog
featur
rna
sequenc
analysi
reveal
viru
inde
new
member
genu
phleboviru
bunyavirida
famili
tem
also
success
use
elucid
unexplain
symptom
small
transmiss
cluster
even
isol
case
use
exampl
case
graft
dysfunct
fever
alter
mental
statu
transplant
recipi
unit
state
viru
arenavirida
famili
observ
ultrathin
section
vero
cell
grown
presenc
cerebrospin
fluid
sampl
one
pcr
use
character
viru
detail
identifi
lymphocyt
choriomening
viru
lcmv
arenaviru
transmit
rodent
tem
also
use
identifi
west
nile
viru
skin
specimen
patient
enigmat
hemorrhag
fever
unit
viru
identifi
visual
ultrathin
section
vero
cell
grown
presenc
homogen
skin
biopsi
specimen
sever
case
bunyaviru
infect
also
diagnos
tem
patient
bitten
mosquito
tick
unit
state
present
fever
fatigu
austria
tem
identifi
picornavirus
urin
sampl
group
neonat
born
hospit
suffer
ill
neg
result
obtain
initi
microbiolog
tem
also
made
possibl
direct
detect
brain
tissu
polyomaviru
jc
viru
respons
case
fatal
progress
multifoc
leukoencephalopathi
absenc
viral
dna
cerebrospin
figur
tem
still
occasion
use
case
human
gastroenter
identif
new
subtyp
causal
virus
recogn
molecular
techniqu
thu
recent
year
role
tem
diagnosi
viral
infect
shift
routin
use
initi
screen
test
identif
unknown
infecti
agent
particular
outbreak
viral
transmiss
cluster
investig
underli
principl
techniqu
major
advantag
recognit
unknown
agent
virus
variou
famili
differ
morpholog
appear
use
basi
initi
viru
identif
tem
method
allow
open
view
sometim
reveal
unexpect
infecti
agent
molecular
method
requir
previou
knowledg
viru
test
tem
also
advantag
abl
potenti
identifi
doubl
multipl
infect
caus
one
viru
could
miss
molecular
antigen
test
moreov
natur
sampl
analyz
divers
bodi
fluid
biopsi
analyz
directli
cell
cultur
case
tem
also
use
confirm
diagnosi
previous
establish
molecular
figur
illustr
detect
reoviru
strain
cell
cultur
presenc
urin
throat
swab
specimen
two
children
unexplain
neurolog
symptom
enceph
case
tem
confirm
result
molecular
techniqu
contribut
identif
previous
unknown
reoviru
strain
etiolog
agent
veterinari
medicin
tem
frequent
prove
use
identif
viru
respons
particular
outbreak
serum
convalesc
domest
wild
anim
prove
use
detect
unknown
etiolog
agent
situat
altern
diagnost
method
unsuccess
due
lack
immunolog
reagent
tem
also
consid
import
method
assess
viral
safeti
biopharmaceut
product
tem
recommend
guidelin
us
food
drug
administr
fda
european
medicin
agenc
emea
also
specifi
materi
test
includ
cell
line
cultur
supernat
ferment
bulk
although
limit
sensit
tem
recommend
particular
properti
complementari
approach
vitro
assay
molecular
techniqu
current
regul
use
compon
biopharmaceut
product
stipul
number
manufactur
measur
implement
minim
potenti
risk
viral
contamin
vitro
assay
viru
detect
use
select
cell
line
histori
success
use
detect
wide
rang
potenti
viru
use
test
cultur
medium
cell
bank
test
raw
materi
bovin
serum
growth
factor
use
cell
cultur
howev
infect
occur
cultur
cell
without
cytopath
effect
infect
may
miss
variou
molecular
assay
use
fluoresc
revers
transcript
fpert
specif
retrovirus
test
specif
risk
identifi
risk
evalu
combin
method
possibl
cover
broad
spectrum
potenti
contamin
although
never
possibl
provid
guarante
unwant
agent
present
context
tem
constitut
addit
check
viral
safeti
test
biolog
product
document
possibl
presenc
virus
particl
master
cell
bank
ferment
bulk
harvest
rodent
cell
line
wide
use
manufactur
recombin
protein
pharmaceut
use
human
monoclon
antibodi
vaccin
viral
vector
gene
therapi
cell
line
long
known
contain
retrovir
element
rodent
genom
contain
mani
copi
endogen
viral
particl
produc
cell
intracytoplasm
intracistern
particl
defect
noninfecti
figur
howev
particl
particl
bud
cell
surfac
may
infect
nonrod
figur
murin
retrovirus
shown
tumorigen
case
leukemia
report
children
sever
combin
immunodefici
treat
gene
therapi
involv
use
murin
retrovir
element
demonstr
relev
track
presenc
retrovirus
biolog
product
deriv
rodent
cell
revers
transcriptas
assay
perform
bulk
harvest
often
hamper
high
background
level
due
dna
tem
may
therefor
help
document
presenc
particl
bulk
harvest
figur
tem
also
use
gaug
concentr
viral
particl
valid
clearanc
retrovirus
viru
suspect
present
master
cell
bank
fortun
endogen
retrovirus
present
chines
hamster
ovari
cho
cell
line
main
rodent
cell
line
use
produc
biolog
product
biotech
industri
shown
test
requir
lower
cell
line
cell
line
experi
limit
nevertheless
novel
cell
substrat
includ
insect
cell
line
particular
introduc
biotech
use
carri
new
concern
unknown
virus
potenti
risk
contamin
tem
undoubtedli
use
document
presenc
virus
particl
cell
product
deriv
conclus
although
tem
sometim
seen
somewhat
techniqu
still
import
role
play
viru
detect
particularli
use
identifi
unknown
agent
involv
particular
outbreak
transmiss
cluster
routin
diagnosi
may
use
confirm
even
case
guid
diagnosi
viral
infect
tem
also
use
check
viral
safeti
biopharmaceut
product
techniqu
sever
disadvantag
cost
electron
microscop
mainten
need
microscopist
analysi
particularli
sampl
must
embed
resin
cut
ultrathin
section
howev
techniqu
avail
benefit
disadvantag
complementari
natur
mean
advantag
gain
use
combin
respect
princip
advantag
tem
abil
provid
imag
viru
provid
addit
confid
result
author
compet
interest
